Scienture Holdings, Inc. — Director's Dealing 2024

Aug 5, 2024

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TRxADE HEALTH, INC (MEDS)
CIK: 0001382574
Period of Report: 2024-07-25

Reporting Person: Shankar Hariharan (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.00001	81863	Direct
Common Stock, par value $0.00001	15224	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series X Non-Voting Convertible Preferred Stock	$0		Common Stock (1916816)		Direct
Series X Non-Voting Convertible Preferred Stock	$0		Common Stock (356480)		Indirect

Footnotes

F1: These securities of TRxADE HEALTH, INC. (the "Issuer") were issued in connection with the closing of the acquisition of Scienture, Inc. ("Scienture") by the Issuer on July 25, 2024 (the "Merger") pursuant to an Agreement and Plan of Merger entered into by the Issuer, certain subsidiaries of the Issuer, and Scienture (the "Merger Agreement").

F2: These shares of the Issuer's Series X Non-Voting Convertible Preferred Stock, par value $0.00001 per share (the "Preferred Stock"), have no expiration date. On the 20th calendar day following the mailing of an information statement on Schedule 14C that the Issuer is filing with the Securities and Exchange Commission and mailing to its stockholders in connection with the closing of the Merger, these shares of Preferred Stock will automatically convert on a 1-for-1 basis into fully paid and nonassessable shares of the Issuer's common stock, par value $0.00001.